Merck Fellows Share Skills for Drug Discovery

September 25th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: Seattle | Sept. 25, 2018: As part of the prestigious Merck Fellowship for Global Health program, IDRI (Infectious Disease Research Institute) is hosting three Fellows in Seattle for three months to assist IDRI scientists in implementing drug [...]

New Diagnostic Test for Leprosy Being Developed

September 19th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: Seattle | Sept. 19, 2018: Before an infectious disease can be treated, it must be detected. Key attributes of successful diagnostic tests include speed and cost, but it is also critical that they are easy to administer [...]

IDRI Partners with Alexandria Real Estate Equities, Inc. for Summer Internship

July 31st, 2018|Press Releases|

FOR IMMEDIATE RELEASE: Seattle | Aug. 1, 2018: Five years ago, IDRI (Infectious Disease Research Institute) moved into a state-of-the-art lab at 1616 Eastlake Avenue East, which is owned and operated by Alexandria Real Estate Equities, Inc. (NYSE: ARE), in [...]

Publication Details IDRI’s Promising Leprosy Vaccine Candidate

April 26th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE | April 26, 2018: A publication in Nature Partner Journals (npj) Vaccines indicates that post-exposure prophylaxis with LepVax, IDRI’s leprosy vaccine candidate, not only appears safe but, unlike BCG (a tuberculosis vaccine that provides some protection [...]

IDRI Names New Chief Operating Officer and Chief Scientific Officer

April 6th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE | April 6, 2018: As IDRI (Infectious Disease Research Institute) celebrates its 25th anniversary in 2018, the organization is developing a strategic plan to hone current strengths while embarking upon bold new initiatives including next generation [...]

IDRI Partners to Develop a New Vaccine to Prevent Transmission of Malaria

March 29th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE | March 29, 2018: The Global Health Innovative Technology Fund (GHIT) has awarded the University of Florida (UF) and partners, including IDRI (Infectious Disease Research Institute), $3.2 million to advance a promising vaccine to prevent transmission [...]

IDRI TB Vaccine Candidate Shows Success in Initial Trial

March 24th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE | March 24, 2018 : Researchers at IDRI (Infectious Disease Research Institute), the South African Tuberculosis Vaccine Initiative (SATVI) at the University of Cape Town (UCT) and Aeras have released the first results from a clinical trial [...]

IDRI Receives $3.8 Million for TB Drug Discovery

March 23rd, 2018|Press Releases|

FOR IMMEDIATE RELEASE: Seattle | March 23, 2018: IDRI’s tuberculosis drug discovery efforts continue to expand with a recently awarded grant extension of $3.8 million from the Bill & Melinda Gates Foundation. The additional funding was awarded to Tanya [...]

Seattle Lawyer Cindy Runger Joins IDRI Board of Directors

October 19th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: Seattle, WA | Oct. 19, 2017: Cindy Runger, a senior finance and legal executive who most recently served in a leadership role with U.S. Trust, has joined the Board of Directors of IDRI (Infectious Disease Research [...]

Promising New Leprosy Vaccine Moves into Human Trials

October 12th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE, WA, & GREENVILLE, SC | Oct. 12, 2017: Today marks a significant step forward in the prevention and treatment of leprosy as the Infectious Disease Research Institute (IDRI) and American Leprosy Missions announce the start of a [...]

Load More